Durable SARS-CoV-2 Antibodies Bind to Two Viral Targets at Once
A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks. That’s right: marks. Instead of targeting a single…